These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 2847292)

  • 1. Ganciclovir therapy for cytomegalovirus infections in recipients of bone marrow transplants and other immunosuppressed patients.
    Winston DJ; Ho WG; Bartoni K; Holland GN; Mitsuyasu RT; Gale RP; Busuttil RW; Champlin RE
    Rev Infect Dis; 1988; 10 Suppl 3():S547-53. PubMed ID: 2847292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ganciclovir treatment of cytomegalovirus disease in transplant recipients and other immunocompromised hosts.
    Erice A; Jordan MC; Chace BA; Fletcher C; Chinnock BJ; Balfour HH
    JAMA; 1987 Jun; 257(22):3082-7. PubMed ID: 3035246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ganciclovir therapy for cytomegalovirus disease associated with renal transplants.
    Snydman DR
    Rev Infect Dis; 1988; 10 Suppl 3():S554-62. PubMed ID: 2847293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ganciclovir treatment of life- or sight-threatening cytomegalovirus infection: experience in 314 immunocompromised patients.
    Buhles WC; Mastre BJ; Tinker AJ; Strand V; Koretz SH
    Rev Infect Dis; 1988; 10 Suppl 3():S495-506. PubMed ID: 2847286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ganciclovir treatment of serious cytomegalovirus infection in heart and heart-lung transplant recipients.
    Keay S; Petersen E; Icenogle T; Zeluff BJ; Samo T; Busch D; Newman CL; Buhles WC; Merigan TC
    Rev Infect Dis; 1988; 10 Suppl 3():S563-72. PubMed ID: 2847294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of cytomegalovirus pneumonia.
    Crumpacker C; Marlowe S; Zhang JL; Abrams S; Watkins P
    Rev Infect Dis; 1988; 10 Suppl 3():S538-46. PubMed ID: 2847291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of ganciclovir for cytomegalovirus disease.
    Fletcher CV; Balfour HH
    DICP; 1989 Jan; 23(1):5-12. PubMed ID: 2541566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ganciclovir therapy in iatrogenically immunosuppressed patients with cytomegalovirus disease.
    Thomson MH; Jeffries DJ
    J Antimicrob Chemother; 1989 Jun; 23 Suppl E():61-70. PubMed ID: 2550413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytomegalovirus retinitis and response to therapy with ganciclovir.
    Henderly DE; Freeman WR; Causey DM; Rao NA
    Ophthalmology; 1987 Apr; 94(4):425-34. PubMed ID: 3035453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of cytomegalovirus pneumonitis with ganciclovir in renal transplantation.
    Stoffel M; Pirson Y; Squifflet JP; Lamy M; Gianello P; Alexandre GP
    Transpl Int; 1988 Dec; 1(4):181-5. PubMed ID: 2855305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of oral acyclovir or ganciclovir therapy after preemptive intravenous ganciclovir therapy to prevent cytomegalovirus disease in cytomegalovirus seropositive renal and liver transplant recipients receiving antilymphocyte antibody therapy.
    Turgeon N; Fishman JA; Basgoz N; Tolkoff-Rubin NE; Doran M; Cosimi AB; Rubin RH
    Transplantation; 1998 Dec; 66(12):1780-6. PubMed ID: 9884276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment and prophylaxis of cytomegalovirus disease.
    Levinson ML; Jacobson PA
    Pharmacotherapy; 1992; 12(4):300-18. PubMed ID: 1325636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of 9-(1,3-dihydroxy-2-propoxymethyl) guanine on serious cytomegalovirus disease in eight immunosuppressed homosexual men.
    Masur H; Lane HC; Palestine A; Smith PD; Manischewitz J; Stevens G; Fujikawa L; Macher AM; Nussenblatt R; Baird B
    Ann Intern Med; 1986 Jan; 104(1):41-4. PubMed ID: 3000248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ganciclovir therapy of severe cytomegalovirus infections in solid-organ transplant recipients.
    Harbison MA; De Girolami PC; Jenkins RL; Hammer SM
    Transplantation; 1988 Jul; 46(1):82-8. PubMed ID: 2839916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ganciclovir prophylaxis for cytomegalovirus infection in pediatric allogeneic bone marrow transplant recipients.
    Canpolat C; Culbert S; Gardner M; Whimbey E; Tarrand J; Chan KW
    Bone Marrow Transplant; 1996 Apr; 17(4):589-93. PubMed ID: 8722360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical aspects of cytomegalovirus retinitis.
    Palestine AG
    Rev Infect Dis; 1988; 10 Suppl 3():S515-21. PubMed ID: 2847288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A risk-adapted approach with a short course of ganciclovir to prevent cytomegalovirus (CMV) pneumonia in CMV-seropositive recipients of allogeneic bone marrow transplants.
    Verdonck LF; Dekker AW; Rozenberg-Arska M; van den Hoek MR
    Clin Infect Dis; 1997 May; 24(5):901-7. PubMed ID: 9142790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ganciclovir treatment of cytomegalovirus disease in immunocompromised children.
    Gudnason T; Belani KK; Balfour HH
    Pediatr Infect Dis J; 1989 Jul; 8(7):436-40. PubMed ID: 2547191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical course of cytomegalovirus (CMV) viremia with and without ganciclovir treatment in CMV-seropositive kidney transplant recipients. Longitudinal follow-up of CMV pp65 antigenemia assay.
    Yang CW; Kim YO; Kim YS; Kim SY; Moon IS; Ahn HJ; Koh YB; Bang BK
    Am J Nephrol; 1998; 18(5):373-8. PubMed ID: 9730559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of cytomegalovirus retinitis with ganciclovir (9-[2-hydroxy-1-(hydroxymethyl) ethoxymethyl] guanine (BW B759U).
    Orellana J; Teich SA; Winterkorn JS; Mathur-Wagh U; Handwerger S; Schlamm H; Malamud SC; Yancovitz SR; Cederberg DM; Mildvan DS
    Br J Ophthalmol; 1988 Jul; 72(7):525-9. PubMed ID: 2843219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.